Eric Chin insider trades: Biomerica (BMRA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | BMRA | ↑ Buy | 6,250 | $1.60 | $10K | Direct | Aug 27, 2026 (1d) |
| Jun 11, 2020 | AMEH | ↑ Buy | 2,040 | $14.90 | $30K | Direct | Jun 12, 2020 (1d) |
| Jun 12, 2019 | AMEH | ↑ Buy | 2,040 | $14.72 | $30K | Direct | Jun 14, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMRA insiders
Open-market trades in the last 12 months
About Eric Chin's insider trades
Eric Chin is a director at Biomerica (BMRA). Since Jun 12, 2019, Eric has reported 3 open-market purchases worth $70K and no sales on SEC Form 4. In the last 12 months: 1 buy ($10K).
Their filings also include grants and awards (6 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.